Dizlin Pharmaceuticals AB
Company Details
Status: Private
Employees: 1-10
Location:
Kungsgatan 64, Stockholm, Stockholm County 11122, SE
Type:
sample
Technology:
sample
sample
sample
About: Dizlin Pharmaceuticals AB is a privately held Swedish research-based pharmaceutical development company with focus on diseases of the central nervous system in general and on developing improved treatment for advanced stages of Parkinson's disease in particular. The company conducts research in collaboration with researchers at the University of Gothenburg and Linköping University in Sweden.
The company has developed a new patented method for treatment of advanced stages of Parkinson's disease. Dizlin Pharmaceuticals has two products in late phase development stage. The first - Infudopa IntraV™ – is administered intravenously to minimize risks associated with surgery on patients with Parkinson's disease. The second – Infudopa SubC™ – is administered as a continuous subcutaneous infusion by means of a portable pump (similar to insulin infusion for diabetes).
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Dizlin Pharmaceuticals AB | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.